NHS failed to use extra cancer drug funds
June 17, 2011Sales and Marketing Cancer, Cancer Drugs Fund, Erbitux, avastin
The million pound fund set up to increase NHS uptake of new cancer drugs was widely underused, with just over …
AZ establishes predictive science centre in Russia
June 17, 2011Research and Development AstraZeneca, Russia, predictive science
AstraZeneca is moving further into Russia with the establishment in St. Petersburg of a facility which aims to better assess …
Lundbeck to file alcoholism pill this year
June 16, 2011Sales and Marketing Biotie, Lundbeck, alcohol
Lundbeck plans to submit its alcohol dependency treatment for European approval later this year after trials showed it to cut …
Biocair appoints new business development managers
June 16, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Biocair has appointed two new business development managers, Natalie Gerrard and Steve Taylor. Natalie Gerrard was promoted internally from within …
Sanofi signs regenerative medicines collaboration
June 16, 2011Research and Development Audion, Sanofi, hearing loss
Sanofi has signed a research pact with Audion Therapeutics to develop regenerative medicines for hearing loss. The company’s two-year deal …
Spiriva mist inhaler safety concerns raised
June 16, 2011Sales and Marketing Boehringer Ingelheim, Spiriva, drug safety
A mist inhaler used to deliver Spiriva to patients with chronic obstructive pulmonary disease (COPD) may be linked to an …
Boehringer-Lilly launch diabetes drug Tradjenta in US
June 16, 2011Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly
Boehringer Ingelheim and Eli Lilly’s new type II diabetes treatment Tradjenta has been launched in the US. Tradjenta (linagliptin) is …
RSA expands
June 16, 2011Business Services appointment, business services
Global life sciences executive search and interim management firm RSA has made a series of new appointments across its business. …
UK government confirms major amendments to Health Bill
June 15, 2011Health and Social Care Bill, NHS reforms
The government will make major amendments to its controversial Health and Social Care Bill, including minimising the scope of regulator …
GSK takes control of China vaccines venture
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines
GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
Arecor and GSK collaborate on vaccine technology
June 15, 2011Manufacturing and Production, Research and Development Arecor, GSK, vaccines
GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
Digital Pharma: Pharmacovigilance, the internet and social media
June 15, 2011Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance
This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …
Teva’s Cephalon acquisition could be delayed
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva
The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …
Merck to develop biosimilar of Pfizer’s Enbrel
June 15, 2011Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar
Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …
Future Forum recommends major amendments to Health Bill
June 14, 2011Health and Social Care Bill, NHS reforms
The role of GPs and competition in the government’s Health Bill should be greatly diluted and its reform programme substantially …
Xceleron appoints Dr Stuart Best
June 14, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …
FDA plea for notice on drug shortages
June 14, 2011Manufacturing and Production FDA, pharma manufacturing
The FDA has asked US drugmakers to give advance warning of production problems which could lead to shortages in available …
Pharma manufacturing news in brief
June 14, 2011Manufacturing and Production pharma manufacturing
Baxter loses first heparin lawsuit, Pfizer plans a branded generics push in China, plus there’s updates from GSK, Hovione and …
Pfizer’s Sandwich site on market as ‘discovery park’
June 14, 2011Research and Development Pfizer, Sandwich, UK pharma
Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …
Merck redesigns drug labels for clarity
June 14, 2011Manufacturing and Production FDA, Labelling, Merck & Co
The FDA has approved a major overhaul of labelling for a range of Merck & Co products, paving the way …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
